Schobel Alexander Mark

Track

Insider profile

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return -21% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Schobel Alexander Mark's trades of Aquestive Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
359.60
Quantity 89,842
Value US$4,998,558
Transaction date
Proposed sale
Price
5.60
Quantity 25,000
Value US$140,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-19 2024-03-15
PlS Planned sale
16,455 -40.9%
362.80
US$4,172,492 		16,455 -40.9% 362.80 US$4,172,492
2024-03-15 2024-03-15
PrS Proposed sale
89,842
359.60
US$4,998,558 		89,842 359.60 US$4,998,558
2024-03-12 2024-03-08
PlS Planned sale
9,350 +8.9%
87.76
US$4,188,645 		9,350 +8.9% 87.76 US$4,188,645
2024-03-08 2024-03-08
PrS Proposed sale
25,000
5.60
US$140,000 		25,000 5.60 US$140,000
2022-06-10 2022-06-08
B Purchase
45,871 +5.5%
0.96
US$44,036 		45,871 +5.5% 0.96 US$44,036
2021-02-10 2021-02-10
PlS Planned sale
23,460 -2.7%
6.75
US$158,355 		23,460 -2.7% 6.75 US$158,355
2021-02-10 2021-02-09
PlS Planned sale
11,540 -1.3%
6.75
US$77,895 		11,540 -1.3% 6.75 US$77,895
2021-02-09 2021-02-08
PlS Planned sale
40,792 -4.5%
6.50
US$265,148 		40,792 -4.5% 6.50 US$265,148
2020-05-11 2020-05-08
PlS Planned sale
40,000 -4.2%
5.00
US$200,000 		40,000 -4.2% 5.00 US$200,000
2020-05-01 2020-04-29
PlS Planned sale
40,000 -3.8%
4.50
US$180,000 		40,000 -3.8% 4.50 US$180,000
2020-05-04 2020-04-27
PlS Planned sale
40,000 -4.1%
4.00
US$160,000 		40,000 -4.1% 4.00 US$160,000
2020-05-04 2020-04-14
PlS Planned sale
40,000 -3.9%
3.70
US$148,000 		40,000 -3.9% 3.70 US$148,000